Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

FDA Accepts Bayer's Filing To Expand KERENDIA Use In CKD Without Diabetes

(RTTNews) - Thursday, Bayer (BYR.L) announced that the U.S. FDA has accepted its supplemental New Drug Application (sNDA) for KERENDIA (finerenone) to treat adults with non-diabetic chronic kidney disease (CKD).

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Health & Medicine

Cost, skills gaps hold back assistive technology access in Africa

NAIROBI, Kenya, Oct 8 – High costs and shortages of skilled personnel are limiting access to assistive technology across Africa, leaving millions of people without products that could improve their…

  • High costs and skills gaps limit assistive tech access in Africa
  • WHO-UNICEF report: 1 billion lack access to assistive products
  • Sub-Saharan Africa faces severe optometrist shortage

More from Thursday 8 October →